home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Stem Cells Turn Brainy

  December, 3 2001 8:52
your information resource in human molecular genetics
Two independent teams of researchers have taken a crucial step toward using human embryonic stem cells to treat nervous system disorders such as Huntington's disease or spinal cord injury. They have succeeded in coaxing human embryonic stem cells to differentiate into brain cell precursors that, when transplanted into mice brains, differentiate further into neurons and other types of brain cells.

Although all cells in the body contain the same set of genes, most cells are "differentiated"-that is, specialized for a particular function. For instance, a cell in the lens of the eye uses a different subset of genes than a bone cell or a brain cell. But a few cells, so-called stem cells, can differentiate into virtually any kind of cell, under the right conditions. However, the specific conditions needed to make a stem cell differentiate into a particular kind of cell are poorly understood.

Now, two papers published in December's Nature Biotechnology describe two slightly different approaches for inducing human embryonic stem cells to differentiate into precursors of brain cells. In both approaches, cells are grown on special surfaces and exposed to different types of signaling molecules, known as growth factors. After the stem cells had changed into brain cell precursors, the researchers transplanted them into the brains of newborn mice and showed that they further differentiated into various kinds of brain cells seen in normal brains. The ability to specifically control the development of embryonic stem cells into brain cells is an important step forward; however, further studies are needed to determine whether these brain cells are functional.

Contact (Authors):

Su-Chun Zhang
The Waisman Center
University of Wisconsin
1500 Highland Avenue
Madison, WI 53705
Email: zhang@waisman.wisc.edu

Benjamin E. Reubinoff
Department of Obstetrics and Gynecology
The Agnes Ginges Center for Human Neurogenetics
Hadassah University Hospital
Jerusalem, Israel
Email: reubinof@md2.huji.ac.il

(News & Views)
Lorenz Studer
Laboratory of Stem Cell & Tumor Biology
Memorial Sloan-Kettering Cancer Center
New York, NY 10021
Email: studerl@mskcc.org

(C) Nature Biotechnology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.